ITI Pharma and Healthcare Fund Regular vs Nippon India Pharma Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹217 Cr | ₹8161 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.35 | 1.82 |
Manager | Rohan Korde | Sailesh Raj Bhan |
ISIN Code | INF00XX01BL5 | INF204K01968 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 3.32% | 4.61% |
6 Month | -4.43% | 0.95% |
1 Year | 16.47% | 13.72% |
3 Year | 23.74% | 25.49% |
5 Year | - | 21.99% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 4.62% | 6.59% |
1 Year | 4.08% | 8.53% |
3 Year | 22.73% | 24.42% |
5 Year | - | 19.8% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 20.48% | 17.67% |
3 Year | 18.71% | 20.32% |
5 Year | - | 20.52% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 15.667% | 15.623% |
Sharp | 0.739% | 0.707% |
Beta | 0.959% | 0.908% |
Alpha | -1.413% | 0.486% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Rohan Korde | Sailesh Raj Bhan |
Total AUM | ₹4626 Cr | ₹96086 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 7.57 | 1.36 |
Mid Cap | 31.22 | 32.78 |
Small Cap | 32.03 | 27.14 |
Large Cap | 29.19 | 38.72 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 8.42 | 1.36 |
Healthcare | 88.76 | 98.64 |
Basic Materials | 2.08 | - |
Industrials | 0.74 | - |
Financial Services | 0 | - |
Top Comparisons
Tata Mid Cap Growth Fund Regular Plan- Growth Option
3Y Returns25.05%
Axis Midcap Fund - Regular Plan - Growth
3Y Returns23.34%
WhiteOak Capital Multi Cap Fund - Regular (G)
3Y Returns0%
Nippon India Multi Cap Fund-Growth Plan-Bonus Option
3Y Returns25.99%
Kotak Equity Hybrid - Growth
3Y Returns18.05%
Edelweiss Aggressive Hybrid Fund - Regular Plan - Growth Option
3Y Returns20.24%
Mirae Asset Nifty MidSmallcap400 Momentum Quality 100 ETF FoF-Reg (G)
3Y Returns0%
UTI ANNUAL INTERVAL FUND II REGULAR PLAN GROWTH
3Y Returns6.26%